Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 83-2594201 · Snapshot of IRS recognition, filing currency, financial health, and governance.
FY2024 filed as a Form 990-N placeholder. The IRS has not yet released this organization’s full Form 990 for FY2024. All data on this profile reflects the most recent substantive 990 filing; the placeholder year appears in the Financials tab with no breakdown.
To provide highly available, affordable and accessible drug therapeutics to all individuals regardless of socioeconomic status. To expand equity in healthcare by increasing public knowledge of treatment regiments and pharmaceutical products. To develop and distribute high quality pharmaceuticals, compliant with applicable governing bodies. To advance scientific research for the betterment of human health. The organization is established exclusively for charitable, educational and scientific purposes under section 501(c)(3) of the internal revenue code, or corresponding section of any future federal tax code. (1) the corporation's purposes shall be so interpreted as to be consistent with section 501(c)(3) of the United States internal revenue code (and successor provisions), no part of its net earnings, if any, shall inure to the benefit of any private shareholder or individual, and the corporation shall not participate or intervene (by publishing or distributing statements or othewise)
Total Revenue
$0
FY2024
Total Expenses
—
FY2024
Net Assets
$0
Program Ratio
—
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.